Wanbury's Tanuku facility granted GMP certificate by ANVISA
    Home » Drug Approval » Wanbury's Tanuku facility granted GMP certificate by ANVISA
Drug Approval

Wanbury's Tanuku facility granted GMP certificate by ANVISA

The inspection conducted from December 16, 2024 to December 20, 2024 by the Brazil Health Regulatory Agency (ANVISA)

  • By IPP Bureau | May 13, 2025

Wanbury Limited's, Andhra Pradesh Tanuku facility has successfully completed the ANVISA (Brazil FDA) inspection with zero observations.

The inspection conducted from December 16, 2024 to December 20, 2024 by the Brazil Health Regulatory Agency (ANVISA) and confirmed strict adherence to cGMP (Current Good Manufacturing Practices).

As a result, ANVISA has granted the Good Manufacturing Practices (GMP) Certificate for the facility and the Good Manufacturing Practices Certificate (CBPF) issued by ANVISA in English and Portuguese Languages.

Upcoming E-conference

Other Related stories

Zydus receives final approval from USFDA for Glatiramer Acetate Injection
Lupin launches Eslicarbazepine Acetate tablets in US
Europe (AGES, Austria) inspects Shilpa Biologicals’ Dharwad site
View More

Interviews

India rema
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex comm
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Our focus
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
View More

Appointments

GMM Pfaudler Group appoints Gregory Gelhaus as Chief Transformation Officer
GMM Pfaudler Group appoints Gregory Gelhaus as Chief Transformation Officer
Abbott India elevates Maithilee Pathare Mistry as CFO
Abbott India elevates Maithilee Pathare Mistry as CFO
Abbott India elevates Anushree Kunhambu as Associate Director - New Product Introduction and Therapy Area Strategy
Abbott India elevates Anushree Kunhambu as Associate Director - New Product Introduction and Therapy Area Strategy
View More

Startup

Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh
Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh
Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital
Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital
Merck Life Science India signs MoU with DPIIT
Merck Life Science India signs MoU with DPIIT
View More

Digitization

Wanbury to implement the SAP S/4 HANA private cloud platform
Wanbury to implement the SAP S/4 HANA private cloud platform
Rockwell Automation empowers NKP Pharma achieve regulatory compliance
Rockwell Automation empowers NKP Pharma achieve regulatory compliance
Honeywell launches AI-assisted automation platform for life sciences manufacturing industry
Honeywell launches AI-assisted automation platform for life sciences manufacturing industry
View More

Latest Stories

LG Chem sets sights on global market with launch of diabetes combination therapy Zemidapa

Borealis advancing sustainability medical devices with the Bornewables

Artemis Medicare Services posts Q4 FY25 consolidated PAT at Rs. 23.02 Cr

Krsnaa Diagnostics posts Q4 FY25 consolidated PAT at Rs. 20.67 Cr

Bliss GVS Pharma posts Q4 FY25 consolidated PAT at Rs. 15.53 Cr

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion
Injection filter needle market to reach $1.73 billion in 2025
Injection filter needle market to reach $1.73 billion in 2025
Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals
Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging
Amcor's Bloom Biorenewables secures $14 million Series A Funding
Amcor's Bloom Biorenewables secures $14 million Series A Funding
Coveris launches circular solution for stretch sleeves with ReCover
Coveris launches circular solution for stretch sleeves with ReCover
UFlex secures USFDA approval for recycled PE in food packaging
UFlex secures USFDA approval for recycled PE in food packaging